HomeInsightsStock Comparison

Kopran Ltd vs Smruthi Organics Ltd Stock Comparison

Kopran Ltd vs Smruthi Organics Ltd Stock Comparison

Last Updated on: Sep 10, 2025

Key Highlights

  • The Latest Trading Price of Kopran Ltd is ₹ 182.25 as of 10 Sep 15:30.
  • The P/E Ratio of Kopran Ltd changed from 5.2 on March 2020 to 21.9 on March 2025 . This represents a CAGR of 27.08% over 6 yearsThe P/E Ratio of Smruthi Organics Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The Market Cap of Kopran Ltd changed from ₹ 109.65 crore on March 2020 to ₹ 845.48 crore on March 2025 . This represents a CAGR of 40.56% over 6 yearsThe Market Cap of Smruthi Organics Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The revenue of Kopran Ltd for the Jun '25 is ₹ 137.77 crore as compare to the Mar '25 revenue of ₹ 175.62 crore. This represent the decline of -21.55% The revenue of Smruthi Organics Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Kopran Ltd for the Jun '25 is ₹ 16.69 crore as compare to the Mar '25 ebitda of ₹ 20.35 crore. This represent the decline of -17.99% The ebitda of Smruthi Organics Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Kopran Ltd changed from ₹ 2.77 crore to ₹ 7.45 crore over 9 quarters. This represents a CAGR of 55.23% The net profit of Smruthi Organics Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Kopran Ltd changed from 55.28 % on March 2021 to 53.94 % on March 2025 . This represents a CAGR of -0.49% over 5 yearsThe Dividend Payout of Smruthi Organics Ltd changed from 13.56 % on March 2020 to 48.24 % on March 2025 . This represents a CAGR of 23.55% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Kopran Ltd

  • Kopran Ltd., incorporated on April 26, 1958, was promoted by the Somani group and is controlled by Parijat Enterprises.
  • The company came out with a public issue at a premium, in Nov.'92, to finance its backward integration project to produce drug intermediates for semi-synthetic drugs, and also to expand its antibiotic facility. Kopran manufactures pharmaceutical finished dosage forms and bulk drugs and distributes electronic equipment.
  • It manufactures semi-synthetic penicillin and is among the world's highest producers in amoxycillin.
  • Kopran also makes penicillin-G acylase, an enzyme made through fermentation.
  • It has technical collaborations with Gesellschaft Fur Biotechnologische, Germany; Yuhan Corporation, South Korea; Ciba Corning Diagnostic, US; and Adac Laboratories, US. Kopran's bulk drug plant has been approved by the US FDA and the UK regulatory authorities.

About Smruthi Organics Ltd

  • Smruthi Organics Limited was incorporated in July, 1989 as a Private Limited Company and was subsequently converted into a Public Limited Company in February, 1995.
  • The Company was promoted by E Purushotham and Shankarrao R Myakal.
  • The Company is a manufacturer of Active Pharmaceutical Ingredient (API) products in the Anti - Diabetic, Anti - Hypertension and Anti - Infectives Therapeutic categories catering to both the Indian domestic as well as rest of the world (ROW) markets, with clients spanning across Asia, Americas, and Africa.
  • It has 2 manufacturing facilities in Solapur, India. The Company set up a plant at Solapur, Maharashtra, to manufacture bulk drugs like diloxanide furoate (inst. cap. : 24 tpa) and sulphadiazine (inst. cap. : 36 tpa).
  • It expanded its activities and product range in 1993-94 by manufacturing metronidazole benzoate, tinidazole, paracetamol and norfloxacin.

Kopran Ltd News Hub

News

Kopran Ltd Spurts 4.13%

Kopran Ltd gained 4.13% today to trade at Rs 163.7. The BSE Healthcare index is up 0.34% t...

Read more

19 Aug 2025 09:30

News

Kopran to hold AGM

Kopran announced that the 66th Annual General Meeting(AGM) of the company will be held on ...

Read more

31 Jul 2025 09:15

News

Kopran to table results

Kopran will hold a meeting of the Board of Directors of the Company on 29 July 2025. Power...

Read more

19 Jul 2025 10:03

News

Board of Kopran recommends final dividend

Kopran announced that the Board of Directors of the Company at its meeting held on 15 May ...

Read more

15 May 2025 16:01

News

Kopran to hold board meeting

Kopran will hold a meeting of the Board of Directors of the Company on 15 May 2025. Powere...

Read more

07 May 2025 14:37

News

Kopran jumps as USFDA inspection at subsidiary's plant concludes smoothly

The United States Food and Drug Administration (USFDA) recently carried out a surveillance...

Read more

28 Apr 2025 15:03

Smruthi Organics Ltd News Hub

News

Smruthi Organics to declare Quarterly Results

Smruthi Organics will hold a meeting of the Board of Directors of the Company on 13 August...

Read more

02 Aug 2025 10:50

News

Board of Smruthi Organics recommends final dividend

Smruthi Organics announced that the Board of Directors of the Company at its meeting held ...

Read more

05 May 2025 13:58

News

Smruthi Organics AGM scheduled

Smruthi Organics announced that the 36th Annual General Meeting(AGM) of the company will b...

Read more

05 May 2025 13:58

News

Smruthi Organics announces board meeting date

Smruthi Organics will hold a meeting of the Board of Directors of the Company on 5 May 202...

Read more

16 Apr 2025 21:01

News

Smruthi Organics to table results

Smruthi Organics will hold a meeting of the Board of Directors of the Company on 4 Februar...

Read more

23 Jan 2025 14:47

News

Smruthi Organics to table results

Smruthi Organics will hold a meeting of the Board of Directors of the Company on 14 Novemb...

Read more

07 Nov 2024 14:19

SWOT Analysis Of Kopran Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Smruthi Organics Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Kopran Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Smruthi Organics Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Kopran Ltd and Smruthi Organics Ltd

Which company has a larger market capitalization, Kopran Ltd or Smruthi Organics Ltd?

Market cap of Kopran Ltd is 880 Cr while Market cap of Smruthi Organics Ltd is 185 Cr

What are the key factors driving the stock performance of Kopran Ltd and Smruthi Organics Ltd?

The stock performance of Kopran Ltd and Smruthi Organics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Kopran Ltd and Smruthi Organics Ltd?

As of September 10, 2025, the Kopran Ltd stock price is INR ₹182.25. On the other hand, Smruthi Organics Ltd stock price is INR ₹162.0.

How do dividend payouts of Kopran Ltd and Smruthi Organics Ltd compare?

To compare the dividend payouts of Kopran Ltd and Smruthi Organics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions